2S,6S-Hydroxynorketamine hydrochloride

Pricing Availability Delivery Time Qty
Cat.No. 6095 - 2S,6S-Hydroxynorketamine hydrochloride | C12H14ClNO2.HCl | CAS No. 1430202-70-2
Description: Decreases D-serine (a NMDA co-agonist); antidepressant
Chemical Name: (2S,6S)-2-Amino-2-(2-chlorophenyl)-6-hydroxycyclohexanone hydrochloride
Purity: ≥98% (HPLC)
Datasheet
Citations
Literature

Biological Activity

Ketamine metabolite. Decreases intracellular D-serine (a NMDA co-agonist) concentrations in PC-12 cells (IC50 = 0.18 nM). Exerts antidepressant effects in mice.

Licensing Information

Sold under license from the NIH, US patent 62/313,309

Technical Data

M. Wt 276.16
Formula C12H14ClNO2.HCl
Storage Desiccate at RT
Purity ≥98% (HPLC)
CAS Number 1430202-70-2
PubChem ID 124201855
InChI Key ZQJVHBJDLMIKJK-JGAZGGJJSA-N
Smiles ClC1=C([C@]2(N)C([C@@H](O)CCC2)=O)C=CC=C1.Cl

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

All Tocris products are intended for laboratory research use only.

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 27.62 100
water 13.81 50

Preparing Stock Solutions

The following data is based on the product molecular weight 276.16. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 3.62 mL 18.11 mL 36.21 mL
5 mM 0.72 mL 3.62 mL 7.24 mL
10 mM 0.36 mL 1.81 mL 3.62 mL
50 mM 0.07 mL 0.36 mL 0.72 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Product Datasheets

Safety Datasheet

References

References are publications that support the products' biological activity.

Singh et al (2016) Ketamine metabolites enantioselectively decrease intracellular D-serine concentrations in PC-12 cells. PLoS One 11 e0149499 PMID: 27096720

Zanos et al (2016) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533 481 PMID: 27144355


If you know of a relevant reference for 2S,6S-Hydroxynorketamine hydrochloride, please let us know.

Keywords: 2S,6S-Hydroxynorketamine hydrochloride, supplier, Potent, AMPA, agonists, agonism, ketamine, metabolites, antidepressants, ketamine, enantiomer, 2S,6S-HNK, AMPA, Receptors, NMDA, Receptors, Ketamine, and, Metabolites, Ketamine, and, Metabolites, Tocris Bioscience

Citations for 2S,6S-Hydroxynorketamine hydrochloride

Citations are publications that use Tocris products.

Currently there are no citations for 2S,6S-Hydroxynorketamine hydrochloride. Do you know of a great paper that uses 2S,6S-Hydroxynorketamine hydrochloride from Tocris? If so please let us know.

2S,6S-Hydroxynorketamine hydrochloride Reviews

Average Rating:

(Based on 0 Reviews)


1 Star
0%
2 Star
0%
3 Star
0%
4 Star
0%
5 Star
0%

Have you used 2S,6S-Hydroxynorketamine hydrochloride?

Submit a review and receive a $25US/€18/£15/$25CAN Amazon gift card if you include an image -$10US/€7/£6/$10CAN Amazon gift card for reviews without an image. Limited to verified customers in USA, Canada and Europe.


Literature in this Area

Addiction

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.

Depression

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.